Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
09/2003
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345920A1 Novel sulfamides and their use as endothelin receptor antagonists
09/24/2003EP1345907A2 7-heterocyclyl quinoline and thieno 2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
09/24/2003EP1345608A2 The use of selective dopamine d4 receptor agonists for treating sexual dysfunction
09/24/2003EP1272489B1 Process for preparing crystalline form i of cabergoline
09/24/2003EP1196419B1 Potassium channel blocking agents
09/24/2003CN1444597A 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
09/24/2003CN1444596A 16 alpha-methyl or ethyl substituted estrogens
09/24/2003CN1444587A Dihydropyridine soft drug and related to composition and method
09/24/2003CN1444585A Crystalline therapeutic agent
09/24/2003CN1444581A 3-indolyl-4-phenyl-1H-pyrrole-2, 5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/24/2003CN1444567A 咪唑衍生物 Imidazole derivatives
09/24/2003CN1444566A Imidazolyl derivatives
09/24/2003CN1444484A Immunotherapy treating bacterial or viral infection at mucosal surface with probiotics, and composition therefor
09/24/2003CN1443560A Medicine for external application for curing vaginitis and its preparation process
09/24/2003CN1443546A Medicine for curing postpartum subinvolution of uterus and its preparation method
09/24/2003CN1443542A Nocardioactinomycetes cell wall skeleton preparation
09/24/2003CN1122032C Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
09/24/2003CN1121867C Medicine for preventing and treating abortion and its preparing process
09/24/2003CN1121866C Chinese medicine for treating man's sexual disfunction and its preparing process
09/23/2003US6624186 Modulators of SKCa, IKCa and BKCa channels.
09/23/2003US6624164 1,3-dihydro-2H-indol-2-one derivatives, preparation method and pharmaceutical composition containing them
09/23/2003US6623730 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
09/23/2003CA2314865C Methods for preventing and treating mastitis
09/23/2003CA2082424C Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity
09/18/2003WO2003076565A2 Methods of using 46828, a human acyl-coa synthetase
09/18/2003WO2003076443A1 Spiro compounds with npy antagonistic activity
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076436A1 Derivatives of 4- (imidazol-5-yl)-2-(4-sulfoanilino) pyrimidine with cdk inhibitory activity
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076427A1 Quinazoline compounds useful in therapy
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076406A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003WO2003076401A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076400A1 New inhibitors of histone deacetylase
09/18/2003WO2003076397A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003WO2003076393A1 Salts of nateglinide
09/18/2003WO2003075929A1 Inhibitors of histone deacetylase
09/18/2003WO2003075921A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
09/18/2003WO2003075916A1 A non-hormonal approach to male contraception
09/18/2003WO2003075915A1 5-}2-hydroxy-3-`1-(3-trifluoromethylphenyl)-cyclopropyl!-propionylamino}- phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replacement therapy
09/18/2003WO2003075857A2 Amino-methyl substituted tetracycline compounds
09/18/2003WO2003075847A2 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
09/18/2003WO2003075741A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
09/18/2003WO2003059252A3 Use of a novel cell surface protease from group b streptococcus
09/18/2003WO2003028600B1 Wipe formulation
09/18/2003WO2002062391A3 Method of using a cyclooxygenase-2 inhibitor and sex steroids as a combination therapy for the treatment and prevention of dismenorrhea
09/18/2003WO2002011706A3 Drugs for sex dysfunctions
09/18/2003WO2002007757A3 Prevention and treatment of sexual arousal disorders
09/18/2003US20030176686 Diagnosis, therapy; animal growth regulators; controlling cell differentiation; antiiinflammatory agents, antihistamines, Crohn's disease, anticancer agents, autoimmune disease
09/18/2003US20030176491 For therapy and prophylaxis of prostatitis or interstitial cystitis, inflammatory bowel disease, Crohn's disease, ulcerative proctitis, or colitis, prostatic hypertrophy, uterine leiomyomas, breast cancer, endometrial cancer
09/18/2003US20030176481 Novel imidazole derivatives with anti-inflammatory activity
09/18/2003US20030176453 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
09/18/2003US20030176425 Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
09/18/2003US20030176416 For therapy of disease, disorder or condition is responsive to modulation of cholinergic receptors and/or monoamine receptors
09/18/2003US20030176413 Polycyclic guanine derivative phosphodiesterase V inhibitors
09/18/2003US20030176405 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens
09/18/2003US20030176404 Progestogen-anti-progestogen regimens
09/18/2003US20030176331 Having therapeutic, diagnostic, and preventative benefits, particularly as immunotoxins; for therapy of cancer
09/18/2003US20030175969 Prevention infant blood disorders
09/18/2003US20030175920 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
09/18/2003US20030175881 Nucleic acids encoding (poly) peptides having chips activity
09/18/2003US20030175280 Antagonists to chaperonin 10
09/18/2003US20030175279 Diagnosing and prophylaxis of tumors, endometriosis and fibroids, by administering Endometrial Steroid Binding Protein II (ESBPII) antagonists, then analyzing the polypeptide concentration in cells, tissues or fluids
09/18/2003US20030175274 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents
09/18/2003US20030175209 Image diagnosis of a brain tumor, renal carcinoma; tumor treatment therapies, immunotherapy
09/18/2003CA2482191A1 Spiro compounds with npy antagonistic activity
09/18/2003CA2479065A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003CA2479027A1 A non-hormonal approach to male contraception
09/18/2003CA2479016A1 Quinazoline compounds useful in therapy
09/18/2003CA2478948A1 5-}2-hydroxy-3-`1-(3-trifluoromethylphenyl)-cyclopropyl!-propionylamino}-phtalide and related compounds with progesterone receptor modulating a ctivity for use in fertility control and hormone replacement therapy
09/18/2003CA2478701A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino) pyrimidine with cdk inhibitory activity
09/18/2003CA2478652A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003CA2478599A1 Salts of nateglinide
09/18/2003CA2478522A1 Novel curcuminoid-factor viia constructs as suppressors of tumor growth and angiogenesis
09/18/2003CA2478317A1 Methods of preventing or treating disorders by administering an integrin .alpha.v.beta.3 antagonist in combination with an hmg-coa reductase inhibitor or a bisphosphonate
09/17/2003EP1344779A1 Azolo-pyrimidines
09/17/2003EP1344777A1 Imidazole derivatives, process for their preparation and their use
09/17/2003EP1344527A1 Preventives or remedies for endometriosis or uterine myoma
09/17/2003EP1343806A1 Methylene steroids as novel androgens
09/17/2003EP1343804A1 14(15)-unsaturated 15- and/or 16- substituted androgens with mixed androgen-progestational profile
09/17/2003EP1343786A1 Novel pyridine-substituted pyrazolopyridine derivatives
09/17/2003EP1343784A2 Urea substituted imidazoquinoline ethers
09/17/2003EP1343775A2 Piperazine derivatives
09/17/2003EP1343768A1 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands
09/17/2003EP1343759A1 Benzo(f) isoindol derivatives and their use as ep4 receptor ligands
09/17/2003EP1343517A2 Survical promoting ncam binding and ncam ligand biding compounds
09/17/2003EP1343509A2 Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy
09/17/2003EP1343508A1 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis
09/17/2003EP1343506A1 Pharmaceutical formulation containing pyrazolo 4,3-d]pyrimidines and antithrombotic agents, calcium-antagonists, prostaglandins or prostaglandin derivatives
09/17/2003EP1343490A1 Choline pyruvate, method for the production thereof, formulations containing choline pyruvate and the use thereof
09/17/2003EP1343485A2 Lipid-based nitric oxide donors
09/17/2003EP1200445B1 Thienopyranecarboxamide derivatives
09/17/2003EP1192163B1 DITHIEPINO 6,5-b]PYRIDINES, AND RELATED COMPOSITIONS AND METHODS
09/17/2003EP1187627B1 Uses of h-trek-1 polypeptides and polynucleotides encoding them
09/17/2003EP1123296B1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION
09/17/2003CN1443195A LHRH-antagonists, production and use thereof as medicament
1 ... 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 ... 557